東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cardiovascular complications in canc...

Russo, Antonio.

FindBook

Google Book

Amazon

博客來

Cardiovascular complications in cancer therapy

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cardiovascular complications in cancer therapy/ edited by Antonio Russo ... [et al.].
其他作者:	Russo, Antonio.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	xiii, 224 p. :ill. (some col.), digital ;24 cm.
內容註:	Introduction -- Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy -- Molecular Mechanisms of Cardiovascular Damage Induced by Anti HER2 Therapies -- Cardiovascular Damage Induced by Radiotherapy -- Cardiovascular Damage Induced by Anti-VEGF Therapy -- Cardiovascular Damage Induced by Anti-BCR-ABL TKIs -- Heart Failure and Left Ventricular Dysfunction -- Coronary Artery Disease -- Peripheral Artery Disease and Stroke -- Valvular Heart Disease -- Arterial Hypertension -- Atrial Fibrillation in Cancer -- Management of QT Prolongation Induced by Anti-cancer Drugs -- Pulmonary Hypertension Induced by Anti-cancer Drugs -- Venous Thromboembolism -- Early Detection of Cardiac Damage -- Diagnosis of Cardiac Damage: Role of Stress Echo -- Early Detection and Monitoring of Vascular Damage -- Prevention and Clinical Management of Cardiovascular Damage Induced by Anticancer Drugs: Need for Early Biomarkers and Cardio- and Vasculo-Protection in Personalized Therapy -- Cardiovascular Damage in Clinical Trials.
Contained By:	Springer eBooks
標題:	Cancer - Treatment -
電子資源:	https://doi.org/10.1007/978-3-319-93402-0
ISBN:	9783319934020

Cardiovascular complications in cancer therapy
Cardiovascular complications in cancer therapy[electronic resource] /edited by Antonio Russo ... [et al.]. - Cham :Springer International Publishing :2019. - xiii, 224 p. :ill. (some col.), digital ;24 cm. - Current clinical pathology,2197-781X. - Current clinical pathology..

Introduction -- Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy -- Molecular Mechanisms of Cardiovascular Damage Induced by Anti HER2 Therapies -- Cardiovascular Damage Induced by Radiotherapy -- Cardiovascular Damage Induced by Anti-VEGF Therapy -- Cardiovascular Damage Induced by Anti-BCR-ABL TKIs -- Heart Failure and Left Ventricular Dysfunction -- Coronary Artery Disease -- Peripheral Artery Disease and Stroke -- Valvular Heart Disease -- Arterial Hypertension -- Atrial Fibrillation in Cancer -- Management of QT Prolongation Induced by Anti-cancer Drugs -- Pulmonary Hypertension Induced by Anti-cancer Drugs -- Venous Thromboembolism -- Early Detection of Cardiac Damage -- Diagnosis of Cardiac Damage: Role of Stress Echo -- Early Detection and Monitoring of Vascular Damage -- Prevention and Clinical Management of Cardiovascular Damage Induced by Anticancer Drugs: Need for Early Biomarkers and Cardio- and Vasculo-Protection in Personalized Therapy -- Cardiovascular Damage in Clinical Trials.

This book is designed to provide a useful and comprehensive resource and state-of-the-art overview to readers about cardiovascular damage potentially induced by antineoplastic drugs. Thanks to more and more effective antineoplastic treatments, the survival of cancer patients is increasing at an exponential rate. However, the burden of related cardiovascular complications that affect morbidity and mortality are also on the rise. A new branch of cardiology, Cardio-Oncology, was developed to combat this trend. The aim of its conception is to prevent cardiovascular complications related to cancer therapy and to facilitate and avoid interruption of antineoplastic drugs due to the occurrence of cardiovascular damage. The text focuses on cardiovascular complications related to cancer treatment and reviews the pathophysiological mechanisms leading to cardiovascular toxicity related to various antineoplastic drugs. Diagnostic modalities for early diagnosis are also discussed, followed by preventive and therapeutic strategies. Cardiovascular Complications in Cancer Therapy serves as a valuable resource for residents, fellow physicians, medical oncologists, cardiologists, and general practitioners and all those who take care of these patients.

ISBN: 9783319934020

Standard No.: 10.1007/978-3-319-93402-0doiSubjects--Topical Terms:

1244610
Cancer
--Treatment

LC Class. No.: RC270.8 / .C373 2019

Dewey Class. No.: 616.99406

Cardiovascular complications in cancer therapy
LDR:03322nmm a2200337 a 4500 001 2177283
003 DE-He213
005 20190522161742.0
006 m d
007 cr nn 008maaau
008 191122s2019 gw s 0 eng d
020 $a 9783319934020 $q (electronic bk.)
020 $a 9783319934013 $q (paper)
024 7 $a 10.1007/978-3-319-93402-0 $2 doi
035 $a 978-3-319-93402-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.8 $b .C373 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99406 $2 23
090 $a RC270.8 $b .C267 2019
245 0 0 $a Cardiovascular complications in cancer therapy $h [electronic resource] / $c edited by Antonio Russo ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2019.
300 $a xiii, 224 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Current clinical pathology, $x 2197-781X
505 0 $a Introduction -- Mechanisms of Cardiovascular Damage Induced by Traditional Chemotherapy -- Molecular Mechanisms of Cardiovascular Damage Induced by Anti HER2 Therapies -- Cardiovascular Damage Induced by Radiotherapy -- Cardiovascular Damage Induced by Anti-VEGF Therapy -- Cardiovascular Damage Induced by Anti-BCR-ABL TKIs -- Heart Failure and Left Ventricular Dysfunction -- Coronary Artery Disease -- Peripheral Artery Disease and Stroke -- Valvular Heart Disease -- Arterial Hypertension -- Atrial Fibrillation in Cancer -- Management of QT Prolongation Induced by Anti-cancer Drugs -- Pulmonary Hypertension Induced by Anti-cancer Drugs -- Venous Thromboembolism -- Early Detection of Cardiac Damage -- Diagnosis of Cardiac Damage: Role of Stress Echo -- Early Detection and Monitoring of Vascular Damage -- Prevention and Clinical Management of Cardiovascular Damage Induced by Anticancer Drugs: Need for Early Biomarkers and Cardio- and Vasculo-Protection in Personalized Therapy -- Cardiovascular Damage in Clinical Trials.
520 $a This book is designed to provide a useful and comprehensive resource and state-of-the-art overview to readers about cardiovascular damage potentially induced by antineoplastic drugs. Thanks to more and more effective antineoplastic treatments, the survival of cancer patients is increasing at an exponential rate. However, the burden of related cardiovascular complications that affect morbidity and mortality are also on the rise. A new branch of cardiology, Cardio-Oncology, was developed to combat this trend. The aim of its conception is to prevent cardiovascular complications related to cancer therapy and to facilitate and avoid interruption of antineoplastic drugs due to the occurrence of cardiovascular damage. The text focuses on cardiovascular complications related to cancer treatment and reviews the pathophysiological mechanisms leading to cardiovascular toxicity related to various antineoplastic drugs. Diagnostic modalities for early diagnosis are also discussed, followed by preventive and therapeutic strategies. Cardiovascular Complications in Cancer Therapy serves as a valuable resource for residents, fellow physicians, medical oncologists, cardiologists, and general practitioners and all those who take care of these patients.
650 0 $a Cancer $x Treatment $x Complications. $3 1244610
650 1 4 $a Oncology. $3 751006
650 2 4 $a Cardiology. $3 861477
700 1 $a Russo, Antonio. $3 1566800
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Current clinical pathology. $3 1566803
856 4 0 $u https://doi.org/10.1007/978-3-319-93402-0
950 $a Medicine (Springer-11650)